Belongs to

• Center for Hematologic Malignancies

Types of Work

["2016"]

[[["Journal Articles",1538],["Meeting Abstracts",1257],["Reviews",76],["Editorials",35],["Book Sections",32],["Research Letters",26],["Conference Papers",15],["Correspondences",8],["Guidelines",4],["Miscellaneous",3],["Book Wholes",1]]]

[2995]

Popular keywords

• animals
• article
• controlled study
• human
• human cell
• humans
• mouse
• nonhuman
• priority journal
• unclassified drug

Recent Works

1. Design of high-specificity binders for peptide–MHC-I complexes

   Journal Article

   Liu, B.; Greenwood, N. F.; Bonzanini, J. E.; Motmaen, A.; Meyerberg, J.; Dao, T.; Xiang, X.; Ault, R.; Sharp, J.; Wang, C.; more...
   Science (2025)

   Fulltext@MSK | Save
2. Belantamab mafodotin in patients with relapsed/refractory multiple myeloma: A real-world experience

   Journal Article

   Hultcrantz, M.; Derkach, A.; Hassoun, H.; Korde, N.; MacLachlan, K.; Mailankody, S.; Patel, D.; Shah, U. A.; Tan, C. R.; Chung, D. J.; more...
   Blood Neoplasia (2025)

   Fulltext@MSK | Save
3. Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed refractory multiple myeloma

   Correspondence

   Sebastian, T.; Rajeeve, S.; Farzana, T.; Firestone, R.; Jurgens, E.; Miller, K.; Costa, B.; Lesokhin, A.; Tan, C.; Shah, G.; more...
   Blood Cancer Journal (2025)

   Fulltext@MSK | Save